FDA’s draft “plausible mechanism” framework gives individualized genetic therapies a clearer path to market, but questions remain, write experts at Morrison Foerster.
The risk of cognitive outsourcing is real. But there is reason for optimism, if students are taught good AI habits early and ...
Morning Overview on MSN
7 foods quietly tied to better sleep, by recent studies
Controlled trials on a small set of common foods are producing consistent, measurable shifts in sleep metrics, and the ...
Scaling effective solutions often stalls in state government because funding systems are not designed to reward proof of ...
Phase I/II study can serve as the primary basis of a Biologics License Application for accelerated approval with FDA ...
Morning Overview on MSN
6 eating patterns researchers say slow brain aging the most, by the data
Long-term cognitive tracking from the Rush Memory and Aging Project has now produced data on six distinct eating patterns ...
Congenital cytomegalovirus occurs in one out of every 200 babies and is the most common infectious cause of hearing loss and ...
AbCellera has an AI-driven antibody discovery platform, $650M liquidity, and an upcoming Phase 2 catalyst. Click here to read ...
Phase I/II study can serve as the primary basis of a Biologics License Application for accelerated approval with FDA ~ ~ Company intends to submit the BLA in third quarter ...
Discusses V012 Study Top-Line Results for Engineered Vessel in Dialysis Access June 15, 2026 5:00 PM EDTCompany ...
Scientists comment on two medical AI models, published in Nature, for patient management. Comments from our friends at SMC Spain: Ignacio Miranda Gómez, head of the Breast Imaging Unit at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results